How do the sensitivities and false positive rates for aneuploidy and gender—the improved PPV for SNP in sex chromosome abnormalities, in particular—compare for the various methodologies?

How do the sensitivities and false positive rates for aneuploidy and gender—the improved PPV for SNP in sex chromosome abnormalities, in particular—compare for the various methodologies?

How do the sensitivities and false positive rates for aneuploidy and gender—the improved PPV for SNP in sex chromosome abnormalities, in particular—compare for the various methodologies?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Peter Benn PhD, DS

Peter Benn PhD, DS

Professor
Department of Genetics and Genome Sciences
University of Connecticut Health Center
Farmington, CT